#United States #St. Paul #iotaMotion #cochlear implant #iotaSOFT

iotaMotion Expands Robotic-Assisted Cochlear Implant Surgery

St. Paul, Minnesota-based iotaMotion, Inc. has recently reached a significant milestone in its pursuit to redefine cochlear implant surgery through advanced robotic-assisted systems. After a successful first year of commercialization, the company now boasts 25 medical centers across the United States implementing its innovative iotaSOFT® Insertion System. This system is the first of its kind to be available for robotic-assisted cochlear implantation, affirming iotaMotion's commitment to enhancing surgical precision and patient outcomes.

The iotaSOFT Insertion System has been engineered to facilitate a controlled insertion of electrode arrays, promising less trauma to the cochlea compared to manual methods. This advancement caters not only to surgeons seeking improved methods but also to patients anticipating a smoother surgical process with potentially better outcomes. The response from the medical community has been equally compelling; iotaMotion reports a 20% year-on-year growth in cochlear implant procedures at certain centers, significantly higher than the average 7% for the industry.

Mike Lobinsky, President and CEO of iotaMotion, expressed pride in their technology’s impact. He noted, "Creating a market for robotic assistance has resulted in exceptional demand, allowing us to expand our reach into ten neurotology fellowship programs—demonstrating a clear need for our system."

Looking ahead to 2025, iotaMotion is poised to accelerate its expansion, bolstered by Series B funding that aims to enhance operational capacities and drive further innovations in cochlear implantation technologies. As part of this strategic growth initiative, the company welcomes industry veteran Jeff Hopkins to its Board of Directors. Hopkins comes with over three decades of experience in medical technology and has a notable history of steering businesses toward success, including a turnaround of the Acclarent ENT division at Johnson & Johnson.

Commenting on his new role, Hopkins stated, "I am excited to take an active role on the board of iotaMotion as they disrupt the cochlear implant industry. The technology is impactful for patients with advanced hearing loss and will broaden adoption of neurotology treatments."

The successful completion of the Series B funding round, along with the addition of Hopkins to the board, reflects the market's confidence in iotaMotion's groundbreaking technology. Lobinsky reiterated the company’s vision, sharing that 2025 will be a hallmark year characterized by growth and the creation of a robust market for robotic assistance in cochlear implantation.

About iotaMotion

Founded in St. Paul, MN, iotaMotion, Inc. is at the forefront of medical technology innovation, particularly in the realm of cochlear implantation. The company dedicates itself to improving surgical outcomes through cutting-edge robotic-assisted technologies that outpace human capabilities in electrode array insertion. By doing so, iotaMotion equips hearing professionals with advanced instruments designed to enhance patient rehabilitation and preserve crucial inner ear structures. For further details, visit www.iotamotion.com or reach out to Wade Colburn, Vice President of Marketing and Clinical via email at [email protected].